Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 24
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Womens Dermatol ; 6(2): 97-98, 2020 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-32258340
2.
J Clin Aesthet Dermatol ; 13(1): 35-37, 2020 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-32082470

RESUMO

Acral myxoinflammatory fibroblastic sarcoma (AMFS) represents a low-grade sarcoma with a high rate of local recurrence that commonly affects the distal extremities. The lesion often presents as a painless mass in the hands or feet. There is no formal standardized treatment protocol for this tumor, but wide surgical excision, with or without adjuvant radiation therapy, is the conventional treatment. We report a case of a patient with an AMFS treated with Mohs micrographic surgery (MMS) without recurrence. Because of the propensity of this tumor to involve acral sites where tissue conservation is important, MMS might be an alternative treatment modality for this rare entity.

4.
Pediatr Dermatol ; 35(1): e74-e75, 2018 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-29231259

RESUMO

A previously healthy 5-year-old girl presented with acute onset of blue toes and red spots on the nose and fingers. The striking nature of these lesions, along with the finding of submandibular lymphadenopathy, prompted further evaluation. Laboratory findings were remarkable for anemia, high transaminase levels, and high blast count. Histopathologic findings were consistent with early pernio. Further examination revealed acute B-cell lymphoblastic leukemia. Treatment of the leukemia led to resolution of the pernio.


Assuntos
Crise Blástica/diagnóstico , Pérnio/etiologia , Leucemia-Linfoma Linfoblástico de Células Precursoras/diagnóstico , Antineoplásicos/uso terapêutico , Crise Blástica/tratamento farmacológico , Pré-Escolar , Feminino , Dedos/patologia , Humanos , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamento farmacológico , Leucemia-Linfoma Linfoblástico de Células Precursoras/patologia , Pele/patologia
6.
Dermatol Surg ; 43(2): 173-187, 2017 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-27608208

RESUMO

BACKGROUND: The specialty of dermatology relies heavily on local anesthesia for diagnosis and management of skin disease. The appropriate selection, preparation, administration, and monitoring of these medications affect surgical outcome and patient safety and satisfaction. OBJECTIVE: To perform a comprehensive literature review of the side effects and risks associated with local anesthetics used in cutaneous surgery. Current recommendations to reduce risk and minimize side effects are reviewed. MATERIALS AND METHODS: A comprehensive review of the English-language medical literature search was performed. RESULTS: No current review articles of the side effects and risks of local anesthetics were identified. This review serves to discuss local anesthetics commonly used in dermatology and cutaneous surgery along with practical information regarding prevention of adverse outcomes and addressing local and systemic reactions when they arise. CONCLUSION: Local anesthetics commonly used in cutaneous surgery have potential risks and side effects. Appropriate selection and utilization of local anesthetics and knowledge of the means to prevent and address these risks can impact surgical outcomes, patient satisfaction and safety, and ultimately patient experience in the dermatology clinic.


Assuntos
Anestésicos Locais/administração & dosagem , Anestésicos Locais/efeitos adversos , Procedimentos Cirúrgicos Dermatológicos , Anestésicos Locais/farmacologia , Comorbidade , Hipersensibilidade a Drogas/etiologia , Humanos , Fatores de Risco , Dermatopatias/cirurgia
7.
Int J Dermatol ; 55(5): e275-9, 2016 May.
Artigo em Inglês | MEDLINE | ID: mdl-26518613

RESUMO

BACKGROUND: Calciphylaxis is a syndrome of vascular calcification most commonly affecting patients with end-stage renal disease (ESRD) on hemodialysis. Because of its high mortality rate, early diagnosis and treatment are necessary. Although diagnosis is usually based on skin biopsy, histopathology is often nonspecific. As the role of imaging in calciphylaxis has not been studied extensively, we examined the utility of radiology in the diagnosis of this disease. METHODS: A thorough review of electronic medical records for 2005-2013 at Loyola University Medical Center yielded 10 patients with biopsy-proven calciphylaxis. Using the radiological picture archiving and communication system (PACS), all imaging studies of the affected body part obtained within 6 months of diagnosis were analyzed and tabulated. RESULTS: All 10 patients had undergone imaging (computed tomography, ultrasound, plain radiography, and/or mammography) of the affected anatomy prior to diagnosis by skin biopsy. Nine of these patients were noted to have moderate-to-severe soft tissue vascular calcification in the area of skin biopsy. CONCLUSIONS: This case series supports the suggestion that findings of superficial vascular calcifications on imaging studies are sensitive for the diagnosis of calciphylaxis. Used in conjunction with histopathological, clinical, and laboratory data, radiology can serve an important role in the diagnosis of calciphylaxis.


Assuntos
Vasos Sanguíneos/diagnóstico por imagem , Calciofilaxia/diagnóstico por imagem , Radiografia , Pele/patologia , Adulto , Idoso , Biópsia , Calciofilaxia/patologia , Feminino , Humanos , Masculino , Mamografia , Pessoa de Meia-Idade , Tomografia Computadorizada por Raios X , Ultrassonografia Doppler em Cores
8.
J Cutan Pathol ; 43(1): 41-52, 2016 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-26423820

RESUMO

BACKGROUND: The lack of highly specific clinical and histopathological criteria has contributed to the delay in diagnosis of subungual melanoma in situ in its early stages. METHODS: Eighteen cases of subungual melanoma in situ, the largest series reported to date, were analyzed to characterize the clinical and histopathological findings of early stages of subungual melanoma in situ along with five cases of nail matrix nevus and five cases of subungual lentigo serving as histologic control. RESULTS: Clinically, longitudinal melanonychia was present in all 18 cases of subungual melanoma in situ, consisting of irregular dark brown to black streaks within a brown background with (11 cases) or without Hutchinson's sign. Histopathologically, variable shaped and sized, hyperchromatic nuclei surrounded by retraction artifact were present in all cases. Nine cases showed a significant increase in the number of atypical melanocytes with marked nuclear atypia, while the rest of the cases showed less noticeable changes in nail matrix including lower density of melanocytes and/or mild nuclear atypia. In 15 cases, the nuclear enlargement in some of the melanocytes was greater than two times that of the neighboring matrix cells. In the remaining three cases, the nuclei were enlarged to a much lesser degree. All cases displayed areas of haphazard and uneven distribution of solitary melanocytes and, although not observed in all cases, some degree of pagetoid spread was present in majority of the cases. In contrast, nail matrix nevi showed well-formed nests consisting of relatively monomorphous melanocytes with abundant cytoplasm and subungual lentigos consisted of subtle increase in the number of dendritic melanocytes in solitary units within the lower layers of the nail matrix. CONCLUSION: Increase in the number of scattered atypical melanocytes with large hyperchromatic nuclei in a partial nail matrix may provide a diagnostic clue to subungual melanoma in situ in concert with its clinical suspicion.


Assuntos
Melanócitos/patologia , Melanoma/diagnóstico , Doenças da Unha/diagnóstico , Adulto , Detecção Precoce de Câncer , Feminino , Humanos , Masculino , Melanoma/patologia , Pessoa de Meia-Idade , Doenças da Unha/patologia
9.
Cutis ; 96(3): E21-2, 2015 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-26562279

RESUMO

Dermatology residency is a time to maximize educational experiences, which include opportunities to attend academic meetings and present research and clinical cases. In this article, resident presentation opportunities at major academic dermatology meetings are reviewed.


Assuntos
Congressos como Assunto , Dermatologia/educação , Internato e Residência/organização & administração , Humanos
10.
Cutis ; 95(6): E28-9, 2015 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-26125220

RESUMO

Local anesthetics are commonly utilized in the practice of dermatology. Minimizing local anesthetic injection pain can be beneficial to both physicians and patients. Easily implemented techniques that reduce injection pain of intralesional local anesthetics are reviewed.


Assuntos
Anestésicos Locais/administração & dosagem , Injeções/efeitos adversos , Dor/prevenção & controle , Soluções Tampão , Dermatologia , Temperatura Alta , Humanos , Agulhas , Dor/etiologia
11.
J Drugs Dermatol ; 14(7): 660-6, 2015 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-26151780

RESUMO

Boxed, or "black box" warnings are issued by the United States Food and Drug Administration (US FDA) as a means to label drugs associated with serious adverse events. However, there is no clear metric to determine how and when the boxed warning is applied. Inconsistencies in the review process, language, timing, and dissemination of these warnings impact dermatologists and their patients. Appropriate patient selection and monitoring can help minimize risk to patients when prescribing drugs with boxed warnings. Future changes in the manner in which the boxed warning is issued and in its subsequent clinical application may improve the utility of these warnings for dermatologists and ultimately, patient safety.


Assuntos
Fármacos Dermatológicos/efeitos adversos , Rotulagem de Medicamentos , Fármacos Dermatológicos/uso terapêutico , Dermatologia , Humanos , Segurança do Paciente , Estados Unidos , United States Food and Drug Administration
12.
Cutis ; 95(3): E31-4, 2015 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-25844794

RESUMO

Postresidency fellowship training options exist for graduating dermatology residents. Formal subspecialty fellowship programs are offered in dermatopathology, pediatric dermatology, micrographic surgery and dermatologic oncology (procedural dermatology), and cosmetic dermatologic surgery. There also are a number of fellowships offered at certain institutions for those interested in more specific subspecialties or academia. This guide serves to assist dermatology residents in learning more about fellowship opportunities.


Assuntos
Dermatologia/educação , Educação de Pós-Graduação em Medicina , Bolsas de Estudo , Internato e Residência , Humanos
13.
Cutis ; 96(6): E11-3, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26761939

RESUMO

Many opportunities exist for residents to get involved in advocacy in dermatology, from national to grassroots levels. Residents also should be aware of opportunities to get involved in patient advocacy and become familiar with the myriad of patient advocacy groups that exist. These groups offer support and education for patients and initiate research efforts for specific dermatologic conditions that provide support for patients beyond what can be offered during a standard office visit. The value of resident involvement in advocacy also is discussed.


Assuntos
Dermatologia , Internato e Residência , Defesa do Paciente , Humanos , Sociedades Médicas/organização & administração , Estados Unidos
14.
Ann Dermatol ; 26(1): 61-5, 2014 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-24648687

RESUMO

BACKGROUND: Vitiligo is an acquired disorder characterized by a progressive loss of melanocytes, which is difficult to manage and has an unknown prognosis. The subtype of segmental vitiligo (SV) has been established but it has not been adequately characterized. OBJECTIVE: To collect long-term follow-up data for evaluating the clinical course of SV. METHODS: This study included 87 patients who were diagnosed with SV and were monitored at a clinic. Patients were classified into the following three groups according to disease activity. RESULTS: Among the patients with SV, 63.2% had stable disease, 14.9% had disease recurrence between two and four years after disease onset, and 21.8% had disease recurrence at four or more than four years after disease onset. Among the 44 patients (50.2%) who were monitored continuously over a four-year period, 19 (43.2%) experienced a recurrence at four or more than four years after disease onset. CONCLUSION: Our results suggest that, contrary to previous reports, some patients with SV may not experience disease stability over an extended period of time. Disease recurrence can occur after years of stability, and we propose that long-term follow-up data can be used to characterize SV. This information about the clinical course of SV has implications for treatment and prognosis.

16.
J Dermatolog Treat ; 24(2): 119-21, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-21801112

RESUMO

The ideal repair mechanism for overcoming barrier disruption in atopic dermatitis (AD) needs to completely eliminate microbe and allergen penetration as well as transepidermal water loss. We propose the hydrogel patch as an innovative approach to complete barrier repair. It is composed of an adhesive, thin, flexible, hydrogel layer on an impermeable urethane surface. We conducted a 6-week pilot study with 15 AD patients, who applied the hydrogel patch over one lesion for 6-8 h daily and triamcinolone (TAC) 0.1% cream twice daily to another lesion. Results after 2-week no treatment follow-up showed hydrogel patch had notable efficacy, and comparable to TAC 0.1% cream. Larger studies are needed to validate these results.


Assuntos
Dermatite Atópica/terapia , Hidrogel de Polietilenoglicol-Dimetacrilato/química , Curativos Oclusivos , Adesivo Transdérmico , Adolescente , Adulto , Dermatite Atópica/tratamento farmacológico , Feminino , Glucocorticoides/administração & dosagem , Humanos , Masculino , Projetos Piloto , Resultado do Tratamento , Triancinolona Acetonida/administração & dosagem
17.
Dermatol Online J ; 18(3): 2, 2012 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-22483513

RESUMO

Treatment of moderate-to-severe plaque psoriasis often requires the use of phototherapy or systemic therapy, which includes immunosuppressants, retinoids, and biologic agents. Although biologic use is becoming increasingly popular, it is not uncommon for patients to experience treatment failure. We describe a patient who had a suboptimal response to etanercept monotherapy after twelve weeks of induction dosing (50 mg twice weekly), as well as to a combination of etanercept (50 mg once weekly-maintenance dosing) and narrowband ultraviolet B (NB-UVB) phototherapy three times weekly for an additional twelve weeks. Noticeable improvement was noted after the addition of NB-UVB and the patient's promising response to phototherapy influenced further management. Etanercept and NB-UVB were discontinued and the patient was initiated on excimer laser treatments twice weekly. After 4 weeks, the patient had a 75 percent reduction in Psoriasis Area Severity Index (PASI) score and after 7 weeks had over 95 percent clearance of psoriasis. The unique properties of the excimer laser may account for its clinical efficacy in our patient as well as in other cases of recalcitrant psoriasis. We propose that the excimer laser be considered in cases of biologic or conventional phototherapy failure in addition to being a standard treatment option or adjunct for the treatment of psoriasis.


Assuntos
Imunoglobulina G/uso terapêutico , Lasers de Excimer/uso terapêutico , Fototerapia , Psoríase/radioterapia , Psoríase/terapia , Receptores do Fator de Necrose Tumoral/uso terapêutico , Adulto , Etanercepte , Humanos , Terapia com Luz de Baixa Intensidade , Masculino , Índice de Gravidade de Doença , Resultado do Tratamento
18.
J Drugs Dermatol ; 11(3): 413-4, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-22395596

RESUMO

The treatment options for psoriasis in HIV-infected individuals are limited due to the immunosuppressive nature of the therapeutic modalities and the patient's immunocompromised state. Etanercept has been shown to be safe and effective in the non-HIV psoriasis population with nearly 20 years of experience. However, there is limited data on the safety of etanercept use in the HIV patient population. The authors report a case of an HIV-infected patient with psoriasis who has remained mostly clear on continuous, uninterrupted etanercept use for over six years.


Assuntos
Infecções por HIV/complicações , Imunoglobulina G/uso terapêutico , Fatores Imunológicos/uso terapêutico , Psoríase/tratamento farmacológico , Receptores do Fator de Necrose Tumoral/uso terapêutico , Adulto , Etanercepte , Humanos , Imunoglobulina G/administração & dosagem , Imunoglobulina G/efeitos adversos , Fatores Imunológicos/administração & dosagem , Fatores Imunológicos/efeitos adversos , Masculino , Psoríase/patologia , Receptores do Fator de Necrose Tumoral/administração & dosagem , Índice de Gravidade de Doença , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...